| [1] | 黄仲义,肖永红,张菁.万古霉素临床应用中国专家共识(2011版)[J].中国新药与临床杂志,2011,30(8):561. |
| [2] | 刘振声,金大鹏,陈增辉.医院感染管理学[M].北京:军事医学科学出版社,2008:328. |
| [3] | 王爱霞,范洪伟,吕玮,等.桑福德抗微生物治疗指南(新译第41版)2011-2012[M].北京:中国协和医科大学出版社,2011:39. |
| [4] | Liu C,Bayer A,Cosgrove SE,et al.Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children[J].Clin infect Dis,2011,52(3):e18. |
| [5] | Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst pharm,2009,66:82. |
| [6] | Rybak MJ.The pharmacokinetic and pharmacodynamic properties of vancomycin[J].Clin Infect Dis,2006,42(Suppl.1):S35 |